ChemoMetec A/S affirmed earnings guidance for the fiscal year 2022/2023. For the year, based on developments in the third quarter of 2022/23, guidance for financial year 2022/23, as announced in connection with the release of the interim report for 2022/23 on 8 February 2023, is maintained. Accordingly, revenue for 2022/23 is expected in the range of DKK 430 million - DKK 460 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
369 DKK | +2.67% | +1.21% | -4.90% |
Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.90% | 910M | |
+75.28% | 12.38B | |
-20.90% | 7.76B | |
+8.01% | 6.61B | |
+12.49% | 5.4B | |
+37.02% | 4.96B | |
-17.23% | 4.75B | |
-25.92% | 3.89B | |
-26.57% | 2.66B | |
+58.74% | 2.45B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023